Inspira Technologies Oxy BHN Ltd (IINN)

[Invest-in-America]

IINN: Let's get goin'!!! (I'm still holdin' your shares, IINN Company!!)

"Why Inspira Technologies (IINN) Stock Is Popping Off
BENZINGA
9:01 AM ET Feb-14-2024
Inspira Technologies Oxy BHN Ltd (IINN.NaE) shares are trading higher by 113.5% to $2.05 Wednesday morning after the company announced the approval of a U.S. Patent for its orbiting blood oxygenation delivery system, VORTX, a component of the INSPIRA ART500 device. Inspira Technologies says this technology is set to disrupt the conventional approach to blood oxygenation by eliminating the need for fiber membranes, thereby minimizing damage to blood cells. CEO Dagi Ben-Noon views this achievement as a pivotal moment in the company’s journey toward enhancing patient care and advancing healthcare technology."

[Invest-in-America]

IINN: The bottom line here?? Let's KICK-ASK now, IINN Company!!!

[Invest-in-America]

IINN: This is now the 'Magic Hour' for Wall Street, generally. If IINN doesn't begin a move UPWARD now, well, not likely that it ever will today, at least. (But I'm still holding all mine.)

PS: If this Firm was headquartered in any place buy ISRAEL, well, its PRICE would already be on the Moon today behind that kind of good news. Bottom line, Israel can NOT be slaughtering 30,000+ of their perceived 'enemies', and then fancy that their firms on Wall Street will do well. "Karma" doesn't work that way. Too bad that I myself did NOT pay enough attention to this sad fact.

[Invest-in-America]

IINN: A little comeback here??

[Invest-in-America]

IINN: Heck, not even a "pop" at all, after the Open. SHOCKING. (Truth be told, Dude, I believe it is that word "ISRAEL" that killed this one.)

[peterus]

yup sick

[madras50]

well that was a quick pop and drop.

[peterus]

out 1.20s

[peterus]

1.25s back in

[Invest-in-America]

IINN: Yep!! (Gonna take awhile, though, for the IMPORTANCE of their news to sink-into the Global Medical Community today, & in the ensuing weeks.)

[peterus]

nice dip 1.50s
lets break 2s today before we see approval in the next few weeks

[Invest-in-America]

IINN: Good MORN, King P-B!!! WOW!!! We gots at least a 5-bagger here, Dude (IMO)!! I saw your's & Lord Peterus's posts on this --- THANKS to both of you!!! And, I saw it too on Benzinga's list. I'm posting the actual LINK to the PR across iHub so others can read it for themselves.
https://www.prnewswire.com/news-releases/inspira-receives-first-ever-us-patent-approval-for-an-orbiting-blood-oxygenation-delivery-system-302061765.html#:~:text=(Nasdaq%3A%20IINN)%20(Nasdaq,the%20revolutionary%20INSPIRA%E2%84%A2%20ART500

[subslover]

Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
94% of the Claims Were Found to be Novel

RA'ANANA, Israel, Feb. 14, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), is a breakthrough medical technology company targeting to supersede mechanical ventilators, has received the first ever U.S. Patent approval for an orbiting blood oxygenation delivery system, a core technology of the revolutionary INSPIRA™ ART500 device. This innovation has 16 claims found to be novel.



https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg


The orbiting blood oxygenation delivery system (VORTX™) is designed to oxygenate blood without fiber membranes, and we believe it is expected to revolutionize the medical landscape. The current fiber technologies used for blood oxygenation cause substantial damage to the patient's blood cells. Unlike the natural laminar blood flow in blood vessels inside the body, in existing fiber oxygenators, the blood is "forced" to flow in a harmful turbulent flow through many layers of fibers while experiencing friction and shear forces within the fiber walls. Since the fiber fabric is a significant resistor to blood flow, high-pressure differences are formed and cause significant damage to the various blood components, including, high hemolysis (breakdown of red cells), damage to white blood cells, activation of the inflammatory system in the body, activation of the immune system, and blood clotting.

We believe that the orbiting blood oxygenation delivery system is another potentially game-changing core technology of the INSPIRA ART500 device, in targeting the $19 billion mechanical ventilation market.

The INSPIRA ART500 is a breakthrough device, designed to empower breathing in patients that are awake, by continuously measuring the patient's blood parameters in real-time, and delivering needed oxygen volume straight into the blood. As the INSPIRA ART500 is to be equipped with the HYLA blood sensor, it is being designed to continuously scan the patient's blood, potentially allowing for real-time detection of changes in patient condition and providing physicians with decision-supportive data.

CEO of Inspira Technologies Dagi Ben-Noon: "We believe that this is a monumental advancement in the landscape of blood oxygenation technologies and a pivotal milestone and another key indicator of the INSPIRA ART500's core technological portfolio."

Inspira Technologies OXY B.H.N. Ltd.

Inspira™ Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (INSPIRA ART), designed to rebalance patient oxygen saturation levels. This technology potentially allows patients to remain awake during treatment while reducing the need for highly invasive, risky, and costly mechanical ventilation systems that require intubation and medically induced coma. The Company's products have not yet been tested or used in humans and has not been approved by any regulatory entity. For more information, please visit our corporate website: https://inspira-technologies.com.

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses intended benefits and uses of its technology, that its technology has the potential to revolutionize the medical landscape, the target market for its product, the potential of its products to allow for real-time detection and the belief that the patent approval is a monumental advancement in the landscape of blood oxygenation technologies. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2022 filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website, www.sec.gov.

[powerbattles]

Fully loaded 1.43 This could go wild.

[Invest-in-America]

IINN: A MONSTER runner here, Admiral Pete, Sir!!!! (As if you didn't already know!! Just kidding!!)

[Invest-in-America]

IINN: Big news --- US Patent, new (non-destructive) way to oxygenate BLOOD.

"Inspira(TM) Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System"

[peterus]

nice news on patent next 510k approval

[NinjaGalaxy36]

$IINN Inspira(TM) Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA(TM) ART Device

https://stockhouse.com/news/press-releases/2024/02/08/inspira-tm-technologies-collaborates-with-a-leading-israeli-medical-center-for

[peterus]

it takes 6 months or 185 days to get approval (510)k could come sooner

[Tim-tom23]

That *

[Tim-tom23]

Can you explain what do you mean by?

[NinjaGalaxy36]

Inspira said in pr in 9.23 that approval will come in next 6 months.

[peterus]

think we will see approval before 20 march

[NinjaGalaxy36]

Inspira technologies signs strategic agreement to enter gulf states with Glo-Med for deployment of 531 ART devices.

The agreement to potentially provide Inspira Technologies with $32.6 million over a 5-year period, subject to regulatory approvals
This adds up to the company’s net income, which was a loss of around 9 million dollars in 2022.
Under the Agreement, Glo-Med shall be designated as the Company's distributor in Saudi Arabia, United Arab Emirates and Bahrain (the "Territory").
Joe Hayon, Inspira Technologies' Co-Founder and President, stated: "This potential expansion into the Gulf states is pivotal for us as we strive to globally distribute our technology for the betterment of patient care."

Matus Knoblich, CEO of Glo-Med, commented: "This agreement is a significant step for us in broadening our range of innovative products to be offered in the healthcare market through our local network of leading distributors in the Territory."

Glo-Med, known for delivering unique healthcare solutions, collaborates with top medical device and biomedical companies worldwide to meet the growing demand for innovative medical devices and related products in
domestic and international markets.

Along with the largest and most prominent healthcare organizations in New York and Florida as clients, Glo-Med has offices and partner companies in the U.S., Latin America, Europe, the Middle East, and Africa, providing extensive access to the global medical network.

https://finance.yahoo.com/news/inspira-technologies-signs-strategic-agreement-133000477.html

[LiloGa]

The company reported another contract worth almost 33 million dollars, here too the huge contract is subject to regulatory approval.... And I ask, when will the approval happen? Expect FDA approval to arrive soon (:

[Tim-tom23]

I see a lot of people disrespecting her here, but message after message she overcomes all doubts

[peterus]

chill lol company has to stop dilution

[MR.Tz]

I think that after the FDA approval for the ART-100 we will see the entry of a mass of buyers.
People will express confidence in the company and its products when they see developments in the first product approval.

[MR.Tz]

sounds amazing.
The average price is excellent as long as it is under $1.
When good news comes we will seem to know each other more than double in my opinion.
Successfully

[LiloGa]

Does anyone know the value of the contracts on art100? And how long are the contracts spread over? In addition.. once FDA approval how do you think the stock will react?

[maestro_of_Ihub]

Chill man I have 610,000 shares and nit worried! Acb 92 cents! Actually we have, not me personally.

[peterus]

volume today 55k and its 55k dump

[peterus]

yup bid support sucks

[maestro_of_Ihub]

Binary play bro! Share price means nothing without real volume!

[maestro_of_Ihub]

Binary play bro! Share price means nothing without real volume!

[peterus]

and gone lol
shorts in control

[MR.Tz]

And here we meet the $1 again.
In my opinion, this is still a price that does not seem close to it after FDA approval if it goes as planned.

[Tim-tom23]

Close to 1$ what are you saying it's going to Affect the price??

[peterus]

agree

[MR.Tz]

This price gives me an option to strengthen at such low prices.
A pleasure for me.
Waiting for the approval of the art100 which is expected to be in the coming months

[peterus]

4k sell 0.89s idiots

[peterus]

0.9s only idiots selling here

[peterus]

180 days days

[MR.Tz]

keep the faith.
ART100 was submitted to the FDA on 9/13/23.
Average decision time for 510K submissions is 135 days.
Approval is coming, could it be soon?

[MR.Tz]

I take advantage of what people throw away.
collect collect and collect.
Any lower price is another opportunity.

[peterus]

lol

[Tim-tom23]

every time people throw cheaply, there will be people here who know what they are doing

[MR.Tz]

We need clinical proof of the performance of the technology and this is what will give trust on the part of many relevant parties in society.
In light of the latest published collaboration I expect to hear positive things soon

[peterus]

is there any proof from succcesful clinical trial you know ?????

[maestro_of_Ihub]

Added 2,100 from 84-86! Stink bids to 67 till March 1, I will take them all